Pharmaceutical industry was founded in the early of 1951 by building the first factory in Iran.
After Islamic revolution, by beginning the war and exit of foreign companies, pharmaceutical industry experienced a difficult period to meet the need of demanded medicine because of poor knowledge and lack of practical experience. Throughout official negotiations and purchasing foreign partie shares, all of them went under the government ownership.
The third development period includes the early of 1991 to 2001 and is known as the development period of pharmaceutical industries. Some new factories had been founded, some ownership changes had happened, 96 percent of medicine consumption in Iran and also 50 percent of materials have been produced domestically.
By strengthening sanctions, pharmaceutical industry has been dealing with different issues. But now with Rouhani’s government policies in health area and joint comprehensive plan of action, the industry condition has been improved.
According to Iran costume’s statistics, in 2015 Iran imported medicine from almost 60 countries, which amounts up to 1.4 billion Dollars and comparing to previous year; it has decreased in terms of value.
Now approximately 46 percent of pharmaceutical’s import are the medicines which have similar domestic items in the country and therefore it seems that the policy of medicine’s import should be considered again in order to support domestic production and Iranian producers.
Germany, Switzerland and United Arab Emirates are the three top countries in terms of import.
Exports to 30 countries are about 100 million Dollars. The main three countries in terms of export are Germany, Afghanistan and Syria.
Ownership and management structure of Iran’s pharmaceutical companies
At the moment,3 holdings including social service investment company (SSIC), Barakat foundation and Melli Bank have 66 percent of medicine market in terms of ownership.
7 out of IMI100 are in pharmaceutical and pharmaceuticals distribution industries.

Pharmaceutical sector is one of the most active listed groups in Tehran Stock Exchange with a share of nearly 18 percent of the market. The index of this industry increased by 58% during 10th July 2015 to 10th July 2016 even though the TEDPIX has risen 10% so it shows the high potential of the industry.
For more information click here!

Pharmaceutical Industry